Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats

Diabetologia

Volumn 41, Issue 11, 1998, Pages 1361-1367

  Vettor, R ^a,d   Pagano, C ^a   Granzotto, M ^a   Englaro, P ^a   Angeli, P ^a   Blum, W F ^b   Federspil, G ^a   Rohner Jeanrenaud, F ^c   Jeanrenaud, B ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d Ospedale 105   (Italy)

Author keywords

Clamp technique; Insulin secretion; Insulin sensitivity; Leptin; Neuropeptide Y; Rat

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; NEUROPEPTIDE Y;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DEOXYGLUCOSE; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCOLYSIS; INFUSIONS, INTRAVENOUS; INSULIN; LEPTIN; MALE; MUSCLE, SKELETAL; NEUROPEPTIDE Y; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

EID: 0031769803     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051077     Document Type: Article

References (47)

1. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37: 1202-1208
2. Zarjevski N, Vettor R, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43: 764-769
3. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753-1758
4. VanDijk G, Bottone AE, Strubbe JH, Steffens AB (1994) Hormonal and metabolic effects of paraventricular hypothalamic administration of neuropeptide Y during rest and refeeding. Brain Res 660: 96-103
5. Abe M, Saito M, Ikeda H, Shimazu T (1991) Increased neuropeptide Y content in the arcuato-paraventricular hypothalamic neuronal system in both insulin-dependent and non-insulin-dependent diabetic rats. Brain Res 539: 223-227
6. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B (1996) Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia 39: 353-356
7. Stephens TW, Basinski M, Bristow PK et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532
8. Taborsky GJ, Beltramini LM, Brown M, Veith RC, Kowalyk S (1994) Canine liver releases neuropeptide Y during sympathetic nerve stimulation. Am J Physiol 266:E804-E812
9. Sundkvist G, Bramnert M, Bergstrom B, Manhem P, Lilja B, Ahren B (1992) Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic disfunction. Diabetes Res Clin Pract 15: 219-226
10. Takahashi K, Mouri T, Itoi K, Sone M, Ohneda M, Murakami O, Nozuki M, Tachihana Y, Yoshinaga K (1987) Increased plasma immunoreactive neuropeptide Y concentrations in phaeochromocytoma and chronic renal failure. J Hypertens 5: 749-753
11. Sundler F, Ekblad E, Hakanson R (1991) The neuroendocrine system of the gut - an update Acta Oncol 30: 419-427
12. Pettersson M, Ahren B, Lundquist I, Bottcher G, Sundler F (1987) Neuropeptide Y: intrapancreatic neuronal localization and effects on insulin secretion in the mouse. Cell Tissue Res 248: 43-48
13. Petterson M, Ahren B (1990) Insulin secretion in rats: effects of neuropeptide Y and noradrenaline. Diabetes Res 13: 35-42
14. Wang ZL, Bennet WM, Wang RM, Ghatei MA (1994) Evidence of a paracrine role of neuropeptide Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone rats. Endocrinology 135: 200-206
15. Ahlborg G, Lundberg JM (1994) Inhibitory effects of neuropeptide on splanchnic glycogenolysis and renin release in humans. Clin Physiol 14: 187-196
16. Ahlborg G, Weitzberg E, Sollevi A, Lundberg JM (1992) Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man. Acta Physiol Scand 145: 139-149
17. Terrettaz J, Jeanrenaud B (1983) In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 112: 1346-1351
18. Pagano C, Granzotto M, Fabris R, Serra R et al. (1997) Lactate infusion to normal rats during hyperglycemia enhances in vivo muscle glycogen synthesis. Am J Physiol 273: R2072-R2079
19. Rossetti L, Giaccari A (1990) Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85: 1785-1792
20. Ferré P, Leturque A, Burnol AF, Penicaud L, Girard J (1985) A method to quantify glucose utilization in vivo in skeletal mucle and white adipote tissue of the anesthetized rat. Biochem J 228: 103-110
21. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J (1983) Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycaemia. Diabetes 32: 35-45
22. Angeli P, Jemenez W, Arroyo V, Mackanzie HS, Zhang PL, Claria J, Rivera F, Brenner BM, Rodes J (1994) Renal effects of natriuretic peptide receptor blockade in cirrhotic rats woth ascites. Hepatology 20: 948-954
23. Pagano C, Englaro P, Granzotto M et al. (1997) Insulin induces rapid changes of plasma leptin in lean but not in genetically obese (fa/fa) rats. Int J Obes 21: 614-618
24. Lundberg JM, Martinsson A, Hemsen A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, Hjemdahl P (1985) Co-release of neuropeptide Y and catecholamines during physocal exercise in man. Biochem Biophys Res Commun 133: 30-36
25. Ahlborg G, Lundberg JM (1991) Splanchnic release of neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol Scand 6: 561-578
26. Zukowska-Grojec Z, Konarska M, McCarty R (1988) Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci 42: 1615-1624
27. Castan I, Valet F, Voisin T, Quideau N, Laburthe M, Lafontan M (1992) Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes Endocrinology 131: 1970-1976
28. 2-adrenergic system. Am J Physiol 265:E74-E80
29. Modin A, Pernow J, Lundberg JM (1993) Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y. Acta Physiol Scand 148: 1-11
30. Clarke J, Beniamin N, Larkin S, Webb D, Maseri A, Davies G (1991) Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man. Circulation 83: 774-777
31. Joshua IG (1991) Neuropeptide Y-induced constriction in small resistant vessels of skeletal muscle. Peptides 12: 37-41
32. Gardiner SM, Bennet T, Compton AM (1988) Regional haemodinamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evand and Brattleboro rats. J Autonomic Nervous System 24: 15-27
33. Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, Jeanrenaud B (1996) Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinology 63: 318-326
34. Alwmark A, Ahren B (1987) Phentolamine reverses NPY-induced inhibition of insulin secretion in isolated rat islets. Eur J Pharmacol 135: 307-311
35. Moltz JH, McDonald JK (1985) Neuropeptide Y: Direct and indirect action on insulin secretion in the rat. Peptides 6: 1155-1159
36. Jamal H, Jones PM, Byrne J, Suda K, Ghatei MA, Kanse SM, Bloom SR (1991) Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and b-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans. Endocrinology 129: 3372-3380
37. Teitelman G, Alpert S, Polak JM, Martinez A, Hanahan D (1993) Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neural proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. Development 118: 1031-1039
38. Sheikh SP, Holst JJ, Skak-Nielsen T et al. (1988) Release of neuropeptide Y in pig pancreas: dual parasympathetic and sympathetic regulation. Am J Physiol 255:G46-G54
39. Pettersson M, Ahren B (1990) Insulin secretion in rats: effects of neuropeptide Y and noradrenaline. Diabet Res 13: 35-42
40. Dunning BE, Ahren B, Bottcher G, Sundler F, Taborsky GM Jr (1987) The presence and actions of neuropeptide Y in the canine endocrine pancreas. Regul Pept 18: 253-265
41. Ahren B, Martensson H, Falck B (1991) Effects of neuropeptide Y on insulin and glucagon secretion in the pig. Neuropeptides 20: 49-55
42. Skoglund G, Gross RA, Bertrand GR, Ahren B, Loubatieres-Mariani MM (1991) Comparison of effects of neuropeptide Y and norepinephrine on insulin secretion and vascular resistance in perfused rat pancreas. Diabetes 40: 660-665
43. Potter KE (1988) Neuropeptide Y as an autonomic neurotransmitter. Pharmacol Ther 37: 251-273
44. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B (1995) The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 44: 1467-1470
45. DeVos P, Saladin R, Auwerx J, Staels B (1995) Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270: 15958-15961
46. Marks JL, Waite K (1996) Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat. J Neuroendocrinology 8: 507-513
47. Marks JL, Waite K (1996) Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. J Neuroendocrinology 9: 99-103